¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ
 ÃÖ¿ì¼ö ±¸¿¬»ó
2012³âµµ Á¦ 98Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ ÃÖ¿ì¼ö ±¸¿¬»ó ¼ö»óÀÚ·Î ¼±Á¤µÇ½ÉÀ» Áø½ÉÀ¸·Î ÃàÇϵ帳´Ï´Ù.
ÃÖ¿ì¼ö ±¸¿¬»ó
  • ºÐ¾ß : ¸ðüžÆÀÇÇÐ
  • ¼º¸í : ÇÑÀ¯Á¤ (°üµ¿ÀÇ´ë)
  • Á¦¸ñ : Correlation of maternal plasma cell-free total DNA and fetal DNA levels with First-Trimester Spontaneous Abortions
  • ºÐ¾ß : ºÎÀÎÁ¾¾çÇÐ
  • ¼º¸í : ÃÖöÈÆ (¼º±Õ°üÀÇ´ë)
  • Á¦¸ñ : Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas:
             Expression of GRIA2 predicts better survival
  • ºÐ¾ß : »ý½Ä³»ºÐºñÇÐ
  • ¼º¸í : ÀÌ»ç¶ó (ÀÌÈ­ÀÇ´ë)
  • Á¦¸ñ : ovarian serous adenocarcinomas: Expression of GRIA2 predicts better survival
  • ºÐ¾ß : ÀϹݺÎÀΰúÇÐ
  • ¼º¸í : ¹Ú¿µ¼¼ (Â÷ÀÇ°úÇдë)
  • Á¦¸ñ : º¹°­°æ ¼¼ÀýÄ®(Lapknife¢ç)ÀÇ ÀÓ»óÀû Àû¿ë